Acadian Asset Management LLC Nuvation Bio Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$2.58 - $3.69 $1.34 Million - $1.92 Million	-521,280 Reduced 44.38%	653,184 $1.91 Million
Q1 2024 May 10, 2024	BUY	$1.46 - $3.97 $771,843 - $2.1 Million	528,660 Added 81.86%	1,174,464 $4.27 Million
Q4 2023 Feb 13, 2024	BUY	$0.96 - $1.53 $510,803 - $814,093	532,087 Added 467.9%	645,804 $973,000
Q3 2023 Nov 13, 2023	BUY	$1.26 - $2.1 $103,359 - $172,265	82,031 Added 258.89%	113,717 $150,000
Q2 2023 Aug 07, 2023	BUY	$1.56 - $1.84 $49,430 - $58,302	31,686 New	31,686 $57,000

158

157M

3.2K

98.7K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $613M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.